subject area of
- Application of a Novel and Rapid Whole Blood Assay for D-Dimer in Patients with Clinically Suspected Pulmonary Embolism Journal Articles
- Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada Journal Articles
- Emicizumab and thrombosis: The story so far Journal Articles
- Emicizumab state‐of‐the‐art update Journal Articles
- Inhibition of human IgE synthesis by anti‐IgE antibodies requires divalent recognition Journal Articles
- Lower-dose emicizumab prophylaxis: can less be more? Journal Articles
- Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study Journal Articles
- Rapid Systematic Screening of Bispecific Antibody Surrogate Geometries for T-Cell Engagement Using DNA Nanotechnology. Journal Articles
- Teclistamab in Relapsed or Refractory Multiple Myeloma Journal Articles
- Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply. Journal Articles
- The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Journal Articles